Current Pharmaceutical Design
Title: Editorial [Hot Topic: Architecture and Design of Non-Drug Therapy for Reactive Oxygen Spcecies (ROS)-Induced Diseases (Executive Guest Editors: Tohru Yoshioka and Mami Noda)]
Volume: 17 Issue: 22
Author(s): Tohru Yoshioka and Mami Noda
Affiliation:
Export Options
About this article
Cite this article as:
Yoshioka Tohru and Noda Mami, Editorial [Hot Topic: Architecture and Design of Non-Drug Therapy for Reactive Oxygen Spcecies (ROS)-Induced Diseases (Executive Guest Editors: Tohru Yoshioka and Mami Noda)], Current Pharmaceutical Design 2011; 17 (22) . https://dx.doi.org/10.2174/138161211797052691
DOI https://dx.doi.org/10.2174/138161211797052691 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
What We Learnt from Randomized Clinical Trials and Cohort Studies of Antioxidant Vitamin? : Focus on Vitamin E and Cardiovascular Disease
Current Pharmaceutical Biotechnology Antiplatelet Therapies: Aspirin at the Heart of New Directions
Cardiovascular & Hematological Disorders-Drug Targets Energy Metabolism in the Normal and in the Diabetic Heart
Current Pharmaceutical Design Small Molecules as SIRT Modulators
Mini-Reviews in Medicinal Chemistry Chest Pain, Panic Disorder and Coronary Artery Disease: A Systematic Review
CNS & Neurological Disorders - Drug Targets Adipobiology for Novel Therapeutic Approaches in Metabolic Syndrome
Current Vascular Pharmacology Adipose Tissue and the Vessel Wall
Current Drug Targets Epigallocatechin-3-gallate(EGCG): Mechanisms and the Combined Applications
Combinatorial Chemistry & High Throughput Screening A Special Focus on Selexipag - Treatment of Pulmonary Arterial Hypertension
Current Pharmaceutical Design Gene Therapy in Cardiovascular Diseases
Current Gene Therapy Aquaporin-1 and Sodium-Hydrogen Exchangers as Pharmacological Targets in Diabetic Atherosclerosis
Current Drug Targets The Role of Transcription Factor Pitx3 in Dopamine Neuron Development and Parkinsons Disease
Current Topics in Medicinal Chemistry Phytochemicals from Peanut (<i>Arachis hypogaea</i> L.) Skin Extract with Potential for Pharmacological Activity
Current Bioactive Compounds Patent Selections:
Current Biomarkers (Discontinued) Antidiabetics: Structural Diversity of Molecules with a Common Aim
Current Medicinal Chemistry Update on the Treatments of Non-Alcoholic Fatty Liver Disease (NAFLD)
Cardiovascular & Hematological Disorders-Drug Targets A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19)
Infectious Disorders - Drug Targets Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
Current Vascular Pharmacology Type 2 Diabetes Mellitus and the Elderly: An Update on Drugs Used to Treat Glycaemia
Current Vascular Pharmacology Molecularly Imprinted Polymers for Selective Solid-Phase Extraction of Verapamil from Biological Fluids and Human Urine
Current Pharmaceutical Analysis